Drive Promotes Education and Awareness of Men’s Health Issues During
Men’s Health Month
WAYNE, Pa.--(BUSINESS WIRE)--Jun. 5, 2018--
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX)
focused on addressing unmet needs in the field of urology, today
announced its sponsorship of the fifth annual “Drive for Men’s Health”
event. Funds raised by this campaign will be donated to Florida
Polytechnic University and Cochrane Urology, a division of Cochrane
Collaboration, to support the latest research, education, and
awareness-generating efforts in the mission to improve men’s health.
The event, now in its fifth consecutive year, is an initiative launched
by Dr. Jamin Brahmbhatt and Dr. Sijo Parekattil, co-directors of The
PUR Clinic (Personalized Urology & Robotics) at South Lake Hospital
in Clermont, Florida. The Drive combines cars, technology, and
educational events to encourage men to talk about their health. As in
years past, Drs. Parekattil and Brahmbhatt will embark on a
cross-country journey in a new BMW i8 June 1st beginning in
Orlando, Florida, with stops in New York, Philadelphia, Columbus,
Chicago, and Houston featuring speakers, events and educational
activities to raise awareness about men’s health. The drive will cover a
distance of 4000 miles and will conclude on June 9th in
Clermont, Florida.
“We’re proud to once again support the Drive for Men’s Health,” said
Dave Amerson, President of the Interventional Urology business unit.
“Drs. Brahmbhatt and Parekattil’s passion for helping men to live their
best and healthiest lives have impacted many men as well as their
partners and families. There are conditions, such as with benign
prostatic hyperplasia (BPH), which men tolerate as an inevitable part of
the aging process. Education is the key factor to getting men in to see
their doctors, receiving preventative care, and maintaining optimal
health.”
Recent NeoTract sponsored surveys of more than 1,000 men and 1,000 women
over the age of 50 in the U.S. aimed to measure the impact of BPH on
couples, as well as ascertain the reasons why men may not be seeking
treatment for their symptoms. More than one-third of male respondents
were not aware these symptoms were signs of a treatable condition,
rather than just a result of aging.
The Drive for Men’s Health reaches 300 million people across the United
States. The Drive will include a fashion show, educational seminars on
nutrition, and cooking demonstrations from noteworthy chefs.
“The fact is that men go to the doctor less frequently than women, and
are less forthcoming about their health when they do visit,” said Dr.
Sijo Parekattil, co-founder of the Drive for Men’s Health. “Our aim is
to increase awareness of men’s health issues and to encourage men to
make their health a priority; part of that means educating them about
safe and simple procedures available today. NeoTract has been an
invaluable partner in this goal. The UroLift System offers a minimally
invasive treatment option to a very common condition, and has the
potential to dramatically increase quality of life for men suffering
from symptoms of an enlarged prostate.”
Nearly 40 million men in the United States are affected by BPH. Not to
be confused with prostate cancer, BPH occurs when the prostate gland
that surrounds the male urethra becomes enlarged with advancing age and
begins to obstruct the urinary system. Symptoms of BPH often include
interrupted sleep and urinary problems, and can cause loss of
productivity, depression and decreased quality of life.
About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive
technology for treating lower urinary tract symptoms due to benign
prostatic hyperplasia (BPH). The UroLift permanent implants, delivered
during a minimally invasive transurethral outpatient procedure, relieve
prostate obstruction and open the urethra directly without cutting,
heating, or removing prostate tissue. Clinical data from a pivotal
206-patient randomized controlled study showed that patients with
enlarged prostate receiving UroLift implants reported rapid and durable
symptomatic and urinary flow rate improvement without compromising
sexual function. Patients also experienced a significant improvement in
quality of life. More than 50,000 men worldwide have been treated with
the UroLift System. Most common adverse events reported include
hematuria, dysuria, micturition urgency, pelvic pain, and urge
incontinence. Most symptoms were mild to moderate in severity and
resolved within two to four weeks after the procedure. The UroLift
System is available in the U.S., Europe, Australia, Canada, Mexico and
South Korea. Learn more at www.UroLift.com.
About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the NeoTract
Interventional Urology Business Unit is dedicated to developing
innovative, minimally invasive and clinically effective devices that
address unmet needs in the field of urology. Our initial focus is
on improving the standard of care for patients with BPH using the
UroLift System, a minimally invasive permanent implant system that
treats symptoms while preserving normal sexual function. Learn more at www.NeoTract.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®,
Weck® and the UroLift® System – trusted brands
united by a common sense of purpose.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180605005468/en/
Source: Teleflex Incorporated
For Teleflex Incorporated
Company Contact:
Jake Elguicze,
610-948-2836
Treasurer and Vice President, Investor Relations
or
Media
Contact:
Nicole Osmer, 650-454-0505
nicole@healthandcommerce.com